4132.TWO
Price:
$30.5
Market Cap:
$5.56B
Golden Biotechnology Corporation operates as a drug discovery and healthy food supplement manufacturing company in Taiwan, the United States, Japan, China, Korea, and Singapore. Its products include Liverty that is used for liver health support and fatigue; Rasle, an auto-immune adjuvant therapy; ZSAINO, a nourishment product for recovery from illness and for health improvement; and UMOOZE, a herbal formula for optimal health in males. The company also provides Antroquinonol, an anticancer molecule for the treatment of pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, as well as hypercholesterolemia and hyperlipidemia. The company was founded in 2002 and is headquarter...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
4132.TWO
According to Golden Biotechnology Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -15.89. This represents a change of 228.06% compared to the average of -4.84 of the last 4 quarters.
The mean historical PE Ratio of Golden Biotechnology Corporation over the last ten years is -19.90. The current -15.89 PE Ratio has changed 7.88% with respect to the historical average. Over the past ten years (40 quarters), 4132.TWO's PE Ratio was at its highest in in the December 2024 quarter at -2.92. The PE Ratio was at its lowest in in the December 2022 quarter at -33.27.
Average
-19.90
Median
-14.81
Minimum
-38.43
Maximum
-6.49
Discovering the peaks and valleys of Golden Biotechnology Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 180.78%
Maximum Annual PE Ratio = -6.49
Minimum Annual Increase = -59.23%
Minimum Annual PE Ratio = -38.43
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -6.49 | -59.23% |
| 2023 | -15.93 | -49.26% |
| 2022 | -31.39 | -18.33% |
| 2021 | -38.43 | 180.78% |
| 2020 | -13.69 | 1.43% |
The current PE Ratio of Golden Biotechnology Corporation (4132.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-17.94
5-year avg
-21.18
10-year avg
-19.90
Golden Biotechnology Corporation’s PE Ratio is greater than InnoPharmax Inc. (-21.12), less than Applied BioCode Corporation (-8.73), less than Winston Medical Supply Co., Ltd. (12.77), less than TSH Biopharm Corporation Limited (18.67), greater than GeneFerm Biotechnology Co., Ltd. (-2565.71), less than Genovate Biotechnology Co., Ltd. (144.46), greater than LIWANLI Innovation Co., Ltd. (-78.49), greater than PhytoHealth Corporation (-41.77), less than Sunny Pharmtech Inc. (-7.79), less than Medtecs International Corporation Limited (-4.49),
| Company | PE Ratio | Market cap |
|---|---|---|
| -21.12 | $2.28B | |
| -8.73 | $2.20B | |
| 12.77 | $1.71B | |
| 18.67 | $2.13B | |
| -2565.71 | $1.94B | |
| 144.46 | $2.76B | |
| -78.49 | $1.91B | |
| -41.77 | $2.76B | |
| -7.79 | $2.10B | |
| -4.49 | $2.51B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Golden Biotechnology Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Golden Biotechnology Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Golden Biotechnology Corporation's PE Ratio?
How is the PE Ratio calculated for Golden Biotechnology Corporation (4132.TWO)?
What is the highest PE Ratio for Golden Biotechnology Corporation (4132.TWO)?
What is the 3-year average PE Ratio for Golden Biotechnology Corporation (4132.TWO)?
What is the 5-year average PE Ratio for Golden Biotechnology Corporation (4132.TWO)?
How does the current PE Ratio for Golden Biotechnology Corporation (4132.TWO) compare to its historical average?